Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Covid save search
Japan's Ministry of Health, Labour and Welfare Approves CSL and Arcturus Therapeutics' ARCT-154, the first Self-Amplifying mRNA vaccine approved for COVID in adults
Published: 2023-11-28 (Crawled : 13:00) - prnewswire.com
QURE | $7.29 3.4% 3.29% 960K
|
Health Technology
|
| O: 0.75%
H: 0.0%
C: 0.0%
ARCT | $23.99 2.35% 2.29% 240K
|
Health Technology
|
| O: 6.36%
H: 0.0%
C: -0.93%
arct-154 covid vaccine approved mrna
Katalin Karikó, Drew Weissman Win Nobel Covid Vaccine Work – Bloomberg
Published: 2023-10-02 (Crawled : 11:00) - spacfeed.com
ACAQ | $2.55 0.0% 1M
|
|
| O: -2.81%
H: 3.2%
C: -42.93%
covid work vaccine
Todos Medical Provides Corporate Update: Retooling to Focus on Long COVID Epidemic
Published: 2023-09-26 (Crawled : 15:30) - globenewswire.com
TOMDF | $0.0004 0.0% 44M
|
Manufacturing
|
| O: 0.0%
H: 0.0%
C: -16.67%
covid medical
60 Degrees Pharma Withdraws COVID Phase IIB IND, Will Resubmit Pending Assessment of Ability to Meet FDA Requirements
Published: 2023-09-18 (Crawled : 20:00) - globenewswire.com
SXTP | $0.653 -1.63% 22K
|
n/a
|
| O: -26.39%
H: 9.41%
C: 1.24%
fda pharma covid
Tonix Pharmaceuticals Announces Topline Results from Phase 2 PREVAIL Proof-of-Concept Study of TNX-102 SL for the Management of Fibromyalgia-Type Long COVID
Published: 2023-09-05 (Crawled : 11:00) - globenewswire.com
TNXP | $0.384 -16.54% -19.82% 4M
|
Health Technology
|
| O: -9.08%
H: 0.0%
C: 0.0%
tnx-102 management covid pharmaceuticals topline results study
Axcella Granted Patent for Long COVID Fatigue Treatment
Published: 2023-08-29 (Crawled : 14:00) - biospace.com/
AXLA | $4.58 -56.33% 42K
|
Health Technology
|
| O: 221.81%
H: 39.94%
C: 23.97%
patent covid granted treatment
Regeneron, J&J Win HHS Funding to Develop Next-Gen COVID Products
Published: 2023-08-23 (Crawled : 12:30) - biospace.com/
JNJ | News | $155.4 -0.78% -0.02% 6.4M
|
Health Technology
|
| O: -0.25%
H: 0.0%
C: 0.0%
covid funding
Novavax's Updated Protein-based XBB COVID Vaccine Induced Neutralizing Responses Against Emerging Subvariants, Including EG.5.1 and XBB.1.16.6
Published: 2023-08-22 (Crawled : 11:00) - prnewswire.com
NVAX | $5.52 -1.08% -1.09% 5.3M
|
Health Technology
|
| O: 14.8%
H: 15.66%
C: 10.36%
covid vaccine
Tonix Pharmaceuticals Completes Clinical Phase of PREVAIL Proof-of-Concept Study of TNX-102 SL for the Treatment of Fibromyalgia-Type Long COVID
Published: 2023-08-07 (Crawled : 11:00) - globenewswire.com
TNXP | $0.384 -16.54% -19.82% 4M
|
Health Technology
|
| O: 2.05%
H: 10.0%
C: 2.0%
tnx-102 covid treatment pharmaceuticals study
Novavax's Nuvaxovid™ Receives Full Marketing Authorization in the EU for the Prevention of COVID
Published: 2023-07-06 (Crawled : 14:00) - prnewswire.com
NVAX | $5.52 -1.08% -1.09% 5.3M
|
Health Technology
|
| O: -1.49%
H: 1.24%
C: -2.62%
covid authorization
Tonix Pharmaceuticals Comments on Two Long COVID Conferences Sponsored by the U.S. National Academies
Published: 2023-07-06 (Crawled : 11:00) - globenewswire.com
TNXP | $0.384 -16.54% -19.82% 4M
|
Health Technology
|
| O: 1.22%
H: 0.0%
C: -6.63%
covid pharmaceuticals
LumiraDx Submits First 510(k) Application to the FDA for COVID Ultra Test
Published: 2023-06-30 (Crawled : 18:00) - globenewswire.com
LMDX | $0.1 -9.01% -9.9% 6M
|
| Email alert
Add to watchlist
fda covid test application
Insider trading bust: Covid corruption, snooping on an investment bank assistant’s laptop, Trump Spac and a cop – Financial News
Published: 2023-06-30 (Crawled : 08:00) - spacfeed.com
OPHV | $ 0%
|
n/a
| Email alert
Add to watchlist
INTS | $3.79 8.6% 7.92% 40K
|
| Email alert
Add to watchlist
USCT | $10.91 0.0% 3.8K
|
n/a
| Email alert
Add to watchlist
covid spac financial
COVID Drug Maker Tevogen To Go Public Via SPAC At $1.2B – Law360
Published: 2023-06-29 (Crawled : 20:00) - spacfeed.com
OPHV | $ 0%
|
n/a
| Email alert
Add to watchlist
USCT | $10.91 0.0% 3.8K
|
n/a
| Email alert
Add to watchlist
drug covid spac
LumiraDx Receives UK CTDA Approval for COVID Ultra and COVID & RSV Tests
Published: 2023-06-20 (Crawled : 20:00) - globenewswire.com
LMDX | $0.1 -9.01% -9.9% 6M
|
|
| O: 30.46%
H: 17.17%
C: -2.98%
covid approval rsv
Novavax Prepared to Deliver Protein-based Monovalent XBB COVID Vaccine Consistent with FDA VRBPAC Recommendation for the Fall
Published: 2023-06-15 (Crawled : 22:00) - prnewswire.com
NVAX | $5.52 -1.08% -1.09% 5.3M
|
Health Technology
|
| O: 1.74%
H: 1.71%
C: -1.95%
fda covid vaccine
NanoViricides Has Filed its Quarterly Report - Clinical Trials of Broad-Spectrum COVID Drug About to Begin
Published: 2023-05-16 (Crawled : 12:00) - biospace.com/
NNVC | $1.17 -0.51% 0.0% 14K
|
Health Technology
|
| O: 0.0%
H: 4.46%
C: -5.36%
drug covid report trials
Access to Novavax's COVID Vaccine Grows with Extended Interim Authorization for Adolescents in Singapore
Published: 2023-05-12 (Crawled : 13:00) - prnewswire.com
NVAX | $5.52 -1.08% -1.09% 5.3M
|
Health Technology
|
| O: 1.46%
H: 3.55%
C: -6.32%
covid vaccine authorization
Positive Phase 2 Topline Results Show Novavax's COVID-Influenza Combination, Stand-alone Influenza and High-dose COVID Vaccine Candidates Demonstrate Robust Immune Responses
Published: 2023-05-09 (Crawled : 12:00) - biospace.com/
SNY | News | $46.06 0.17% 0.17% 1.9M
|
Health Technology
|
| O: -0.58%
H: 0.0%
C: 0.0%
NVAX | $5.52 -1.08% -1.09% 5.3M
|
Health Technology
|
| O: 20.4%
H: 26.64%
C: 6.13%
covid vaccine positive influenza topline results show
NanoViricides is Expanding its Broad-Spectrum Antiviral Program to Explore Further Antiviral Applications of its COVID Clinical Drug Ingredient
Published: 2023-04-25 (Crawled : 12:00) - biospace.com/
NNVC | $1.17 -0.51% 0.0% 14K
|
Health Technology
|
| O: -0.78%
H: 2.36%
C: 2.36%
drug covid antiviral program
Gainers vs Losers
| 69% | 31% |
Top 10 Gainers
SLDB | News M | $5.89 72.22% 41.94% 12M
|
Health Technology
SVFD | News | $3.09 43.72% 30.42% 64M
|
FTEL | $2.04 43.66% 30.39% 110K
|
HPCO 4 | $0.4824 41.92% 29.54% 28M
|
ALGS | News | $0.6475 -5.06% 26.67% 2.1M
|
Health Technology
GTHX | $3.16 30.58% 23.42% 10M
|
Health Technology
KEQU | $22.5 27.62% 21.64% 24K
|
Producer Manufacturing
GSIT | $3.09 27.16% 21.36% 2.2M
|
Electronic Technology
SSKN P | $0.628 25.6% 20.38% 210K
|
Health Technology
GLUE | $3.66 22.82% 18.58% 510K
|
Professional, Scientific, and T...
Your saved searches
Save your searches and get alerts when important news are released.